4 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp06975 | C16-E4Y | EEEEY | Synthetic | Inhibition of cell signalling | WST-8 assay | A-431 | Skin Cancer | 10 % cell viability at 0.05 wt % |
| dbacp06976 | C16-E4Y | EEEEY | Synthetic | Inhibition of cell signalling | WST-8 assay | HeLa | Cervical Cancer | 60% cell viability at 0.05 wt % |
| dbacp06977 | C16-E4Y | EEEEY | Synthetic | Inhibition of cell signalling | WST-8 assay | HepG-2 | Liver Cancer | 50 % cell viability at 0.05 wt % |
| dbacp06978 | C16-E4Y | EEEEY | Synthetic | Inhibition of cell signalling | WST-8 assay | MCF-7 | Breast Cancer | 50 % cell viability at 0.05 wt % |